Chase Investment Counsel’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-6,750
Closed -$1.2M 109
2020
Q1
$1.2M Buy
+6,750
New +$1.27M 0.81% 37
2015
Q4
Sell
-19,245
Closed -$5.23M 102
2015
Q3
$5.23M Sell
19,245
-4,075
-17% -$1.25M 2.11% 19
2015
Q2
$7.08M Sell
23,320
-772
-3% -$230K 2.58% 6
2015
Q1
$7.17M Sell
24,092
-751
-3% -$214K 2.52% 7
2014
Q4
$6.39M Sell
24,843
-3,447
-12% -$862K 2.28% 9
2014
Q3
$6.83M Sell
28,290
-1,092
-4% -$244K 2.45% 4
2014
Q2
$6.55M Sell
29,382
-1,451
-5% -$300K 2.22% 7
2014
Q1
$6.35M Sell
30,833
-15,097
-33% -$2.99M 2.15% 8
2013
Q4
$7.72M Sell
45,930
-31,160
-40% -$4.87M 2.28% 4
2013
Q3
$11.1M Sell
77,090
-12,620
-14% -$1.68M 2.85% 2
2013
Q2
$11.3M Buy
+89,710
New +$10.2M 3.02% 1

Other funds holding AGN

Chase Investment Counsel's AGN Position: Q2 2020 in Review

Chase Investment Counsel sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 6,750 shares — an estimated $1.2M sold.

Chase Investment Counsel first reported a position in AGN in Q2 2013 and held it in 11 quarters. The position peaked at $11.3M in Q2 2013. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Chase Investment Counsel reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Chase Investment Counsel sold 6,750 Allergan plc shares in Q2 2020, an estimated $1.2M.
  • Chase Investment Counsel first reported a position in Allergan plc in Q2 2013 and held it in 11 quarters.
  • Chase Investment Counsel's Allergan plc position peaked at $11.3M in Q2 2013.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Chase Investment Counsel's 13F filing for Q2 2020, filed 5 Aug 2020.